Publication | Closed Access

Curcumol enhances the sensitivity of doxorubicin in triple-negative breast cancer via regulating the miR-181b-2-3p-ABCC3 axis

Breast OncologyMedicineImmunologyBreast CancerCancer BiologyTriple-negative Breast CancerTumor SuppressorAnti-cancer AgentOncologyRadiation OncologyTumor BiologyMir-181b-2-3p-abcc3 Axis